Bio-Techne
TECH
#1834
Rank
โ‚ฌ10.14 B
Marketcap
64,66ย โ‚ฌ
Share price
0.01%
Change (1 day)
25.55%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): 1,01ย โ‚ฌ

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is 1,04ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 0,46ย โ‚ฌ a decrease over its 2024 EPS that were of 0,89ย โ‚ฌ.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)1,01ย โ‚ฌ117.46%
20250,46ย โ‚ฌ-48%
20240,89ย โ‚ฌ-29.58%
20231,27ย โ‚ฌ-14.97%
20221,49ย โ‚ฌ24.16%
20211,20ย โ‚ฌ17.98%
20201,02ย โ‚ฌ-10.94%
20191,14ย โ‚ฌ101.57%
20180,57ย โ‚ฌ-16.99%
20170,68ย โ‚ฌ45.02%
20160,47ย โ‚ฌ-20.97%
20150,60ย โ‚ฌ-14.97%
20140,70ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
16,62ย โ‚ฌ 1,491.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
3,21ย โ‚ฌ 207.69%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
7,64ย โ‚ฌ 631.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
5,04ย โ‚ฌ 382.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
1,77ย โ‚ฌ 69.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-0,19ย โ‚ฌ-117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
7,43ย โ‚ฌ 611.97%๐Ÿ‡บ๐Ÿ‡ธ USA